EP3105246
Miðuð TGF-beta hindrun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.2.2015EP published:
31.3.2021EP application number:
15717097.8
EP translation filed:
15.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
9.2.2035Expiry date:
9.2.2027Next due date:
28.2.2027
Title:
TARGETED TGF BETA INHIBITION
Timeline
Today
10.2.2015EP application
31.3.2021EP Publication
15.6.2021Translation submitted
15.7.2021Registration published
9.2.2027Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
LO, Kin-MingAddress:
Lexington, Massachusetts 02420, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461938048 PDate:
10.2.2014Country:
US
Classification
Categories:
C07K 14/71, C07K 16/22, C07K 16/28, C07K 16/46, C07K 19/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 5.1.2022
Expires: 9.2.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2023
Expires: 9.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2023
Expires: 9.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.1.2024
Expires: 9.2.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.1.2025
Expires: 9.2.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.2.2026
Expires: 9.2.2027
Payer: Árnason Faktor ehf.